A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD

NCT07038200 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Facioscapulohumeral Muscular Dystrophy
FSHD
FSHD - Facioscapulohumeral Muscular Dystrophy
FSHD1
FSHD2
Fascioscapulohumeral Muscular Dystrophy
Fascioscapulohumeral Muscular Dystrophy Type 1
Fascioscapulohumeral Muscular Dystrophy Type 2
Facioscapulohumeral Muscular Dystrophy 1
Facioscapulohumeral Dystrophy
Facio-Scapulo-Humeral Dystrophy
Facioscapulohumeral Muscular Dystrophy 2
Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1)
FSH Muscular Dystrophy
Landouzy Dejerine Dystrophy
Landouzy-Dejerine Muscular Dystrophy
Landouzy-Dejerine Syndrome

Interventions

DRUG: AOC-1020
DRUG: Placebo

Sponsor

Avidity Biosciences, Inc.